Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, replacing v3.6.0 with v3.6.2, reflecting a newer deployment of the page system. This change does not modify study content or related data.
    Difference
    0.1%
    Check dated 2026-06-27T00:12:26.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    New user-help sections were added, and the page revision and verification status indicators were updated to reflect current study details.
    Difference
    2%
    Check dated 2026-06-12T16:48:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, signaling a minor update to the ClinicalTrials.gov record's content/metadata.
    Difference
    0.1%
    Check dated 2026-06-05T12:09:32.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3, indicating a minor metadata update to the page. This update does not modify the actual study details or other visible content.
    Difference
    0.1%
    Check dated 2026-05-15T02:14:50.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.3, replacing v3.5.2. This indicates a small update to the page version rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-04-30T14:21:23.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision update: v3.5.0 replaced by v3.5.2. This update includes backend and UI improvements and does not modify study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-04-16T10:25:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.